About this trial
This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.
Eligibility criteria
Qualifiers
Are aged 35 years or above
is not fully calcified
Is 5-30mm inclusive in maximum axial diameter for the whole lesion measured using manual electronic callipers
Is of a type that meets VNC instructions for use
Disqualifiers
Have received a diagnosis for cancer in the last 5 years
Have thoracic implants that impact the image appearance of the nodule
Have more than five reported pulmonary nodules of any size or type excluding fully calcified nodules (this criterion is used as a proxy due to the risk of being an infection or metastasis)
Are already undergoing follow-up according to pulmonary nodule management standard care
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Nottingham University Hospitals NHS Trust
Lead sponsor
Optellum Ltd.
Collaborator